Besides, the short duration of the LH surge induced by the GnRH agonist to trigger oocyte maturation could explain the notable reduction in the risk of ovarian hyperstimulation syndrome (OHSS) (12). The gene discussed is PLOD1; the disease is ovarian hyperstimulation syndrome.